LA Times Studios has launched the nomination process for its prestigious **2026 Private Equity and M&A Industry Visionaries** category. This initiative aims to recognize influential leaders in the life sciences sector, particularly those who have made significant strides in biotechnology and pharmaceuticals. Professionals involved in funding, strategic guidance, or advisory services related to mergers and acquisitions are encouraged to submit nominations.
The nomination opportunity is open to individuals and organizations that play key roles in private equity and venture capital. This includes investors, bankers, lenders, and professional service advisors such as lawyers and accountants, who have demonstrated a strong commitment to the private equity and M&A sectors. Notably, all nominees must be based in **California**, and up to three individuals from the same firm may be nominated.
Criteria for Selection
The selection process will be handled by the executive committee of LA Times Studios, which will evaluate nominees based on several criteria. These include:
– **Noteworthy successes** and accomplishments achieved in the past **12-24 months**.
– A consistent demonstration of **strong leadership** throughout their careers.
– The **long- and short-term impact** they have made on their organization’s or industry’s growth.
– Involvement in community initiatives and board memberships that reflect their leadership capabilities beyond their immediate roles.
The honorees will be revealed in the **August 2026** edition of the Business by LA Times Studios magazine, which will be distributed alongside the L.A. Times newspaper. There is no fee to nominate, but due to limited publication space, only three profiles from each company will be featured.
Submission Details
Nominations are highly encouraged to be submitted early. Interested parties can reach out to **Karren Adamyan** at **347-8673** or via email at **[email protected]** for any queries regarding the submission process. It is essential to note that once the nomination form is submitted, LA Times Studios staff will not be able to make corrections or revisions. Therefore, nominees should ensure that all provided information is accurate and not confidential or subject to change.
Individuals selected for recognition will be notified approximately **45 days** before publication. As this opportunity highlights the impact of leaders in the private equity and M&A sectors, it serves as an important acknowledgment of the vital role these professionals play in driving innovation and growth in the life sciences industry.
